These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 9815617

  • 1. Expression of fas (CD95/APO-1) antigen induced by radiation therapy for diffuse B-cell lymphoma: immunohistochemical study.
    Ogawa Y, Nishioka A, Hamada N, Terashima M, Inomata T, Yoshida S, Seguchi H, Kishimoto S.
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2211-6. PubMed ID: 9815617
    [Abstract] [Full Text] [Related]

  • 2. Immunohistochemical study of c-fos-positive lymphocytes infiltrated into human squamous cell carcinomas of the head and neck during radiation therapy and its clinical significance.
    Ogawa Y, Nishioka A, Hamada N, Terashima M, Inomata T, Yoshida S, Seguchi H, Kishimoto S.
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2301-7. PubMed ID: 9815628
    [Abstract] [Full Text] [Related]

  • 3. Changes of mutant-type p53 expression in squamous cell carcinoma of the head and neck during radiation therapy and its clinical significance: comparison of an immunohistochemical method and PCR-SSCP assay.
    Ogawa Y, Nishioka A, Hamada N, Terashima M, Inomata T, Yoshida S, Seguchi H, Kishimoto S.
    Oncol Rep; 1998 Dec; 5(5):1053-9. PubMed ID: 9683807
    [Abstract] [Full Text] [Related]

  • 4. Prognostic significance of Fas (CD95/APO-1) positivity in patients with primary nodal diffuse large B-cell lymphoma.
    Eser B, Sari I, Canoz O, Altuntas F, Cakmak E, Ozturk A, Ozkan M, Er O, Cetin M, Unal A.
    Am J Hematol; 2006 May; 81(5):307-14. PubMed ID: 16628716
    [Abstract] [Full Text] [Related]

  • 5. Expression of Fas and Fas-ligand and analysis of argyrophilic nucleolar organizer regions in squamous cell carcinoma: relationships with tumor stage and grade, and apoptosis.
    Guler N, Uckan S, Celik I, Oznurlu Y, Uckan D.
    Int J Oral Maxillofac Surg; 2005 Dec; 34(8):900-6. PubMed ID: 15907374
    [Abstract] [Full Text] [Related]

  • 6. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A, Morris M, Schmidt-Ullrich R, Wu Q, Mohan R, Abayomi O, Buck D, Holdford D, Dawson K, Dinardo L, Reiter E.
    Int J Radiat Oncol Biol Phys; 2004 Oct 01; 60(2):374-87. PubMed ID: 15380569
    [Abstract] [Full Text] [Related]

  • 7. [Application of the immunohistochemical method as predictive assay in radiotherapy of squamous cell carcinoma].
    Ogawa Y, Inomata T, Maeda T, Seguchi H, Nishioka A, Terashima M, Kishimoto S, Saito H, Hirota S, Osaki T.
    Gan No Rinsho; 1988 Oct 01; 34(13):1799-810. PubMed ID: 3264351
    [Abstract] [Full Text] [Related]

  • 8. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M, Dornfeld KJ, Buatti JM, Skwarchuk M, Tan H, Nguyen T, Wacha J, Bayouth JE, Funk GF, Smith RB, Graham SM, Chang K, Hoffman HT.
    Int J Radiat Oncol Biol Phys; 2005 Oct 01; 63(2):410-21. PubMed ID: 16168834
    [Abstract] [Full Text] [Related]

  • 9. Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells?
    Bodey B, Bodey B, Siegel SE, Kaiser HE.
    In Vivo; 1999 Oct 01; 13(4):357-73. PubMed ID: 10586378
    [Abstract] [Full Text] [Related]

  • 10. Amifostine enhances recovery and expansion of peripheral FAS/CD95+ T- and NK-cell subpopulations during radiotherapy of patients with head-neck cancer.
    Koukourakis GV, Baksevanis CN, Zambatis H, Gritzapis A, Maltezos E, Simopoulos C, Koukourakis MI.
    Int J Radiat Biol; 2009 Jan 01; 85(1):96-104. PubMed ID: 19205988
    [Abstract] [Full Text] [Related]

  • 11. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer.
    Müllauer L, Mosberger I, Grusch M, Rudas M, Chott A.
    J Pathol; 2000 Jan 01; 190(1):20-30. PubMed ID: 10640988
    [Abstract] [Full Text] [Related]

  • 12. Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume.
    Chao KS, Ozyigit G, Blanco AI, Thorstad WL, Deasy JO, Haughey BH, Spector GJ, Sessions DG.
    Int J Radiat Oncol Biol Phys; 2004 May 01; 59(1):43-50. PubMed ID: 15093897
    [Abstract] [Full Text] [Related]

  • 13. Fas ligand is expressed on human squamous cell carcinomas of the head and neck, and it promotes apoptosis of T lymphocytes.
    Gastman BR, Atarshi Y, Reichert TE, Saito T, Balkir L, Rabinowich H, Whiteside TL.
    Cancer Res; 1999 Oct 15; 59(20):5356-64. PubMed ID: 10537320
    [Abstract] [Full Text] [Related]

  • 14. FAS death domain deletions and cellular FADD-like interleukin 1beta converting enzyme inhibitory protein (long) overexpression: alternative mechanisms for deregulating the extrinsic apoptotic pathway in diffuse large B-cell lymphoma subtypes.
    Takahashi H, Feuerhake F, Kutok JL, Monti S, Dal Cin P, Neuberg D, Aster JC, Shipp MA.
    Clin Cancer Res; 2006 Jun 01; 12(11 Pt 1):3265-71. PubMed ID: 16740746
    [Abstract] [Full Text] [Related]

  • 15. [The effect of the microenvironment of head and neck cancers on tumor progression].
    Lukits J.
    Magy Onkol; 2009 Mar 01; 53(1):51-9. PubMed ID: 19318327
    [Abstract] [Full Text] [Related]

  • 16. Expression of Fas and Fas ligand in cutaneous B-cell lymphomas.
    Zoi-Toli O, Meijer CJ, Oudejans JJ, de Vries E, van Beek P, Willemze R.
    J Pathol; 1999 Dec 01; 189(4):533-8. PubMed ID: 10629554
    [Abstract] [Full Text] [Related]

  • 17. Localization of Fas antigen in oral squamous cell carcinoma.
    Muraki Y, Yoshioka C, Tateishi A, Fukuda J, Haneji T, Kobayashi N.
    Br J Oral Maxillofac Surg; 1999 Feb 01; 37(1):37-40. PubMed ID: 10203220
    [Abstract] [Full Text] [Related]

  • 18. Prognostic significance of Fas and Fas ligand expressions in human esophageal cancer.
    Shibakita M, Tachibana M, Dhar DK, Kotoh T, Kinugasa S, Kubota H, Masunaga R, Nagasue N.
    Clin Cancer Res; 1999 Sep 01; 5(9):2464-9. PubMed ID: 10499620
    [Abstract] [Full Text] [Related]

  • 19. Frequency of apoptosis of tumor-infiltrating lymphocytes induced by fas counterattack in human colorectal carcinoma and its correlation with prognosis.
    Okada K, Komuta K, Hashimoto S, Matsuzaki S, Kanematsu T, Koji T.
    Clin Cancer Res; 2000 Sep 01; 6(9):3560-4. PubMed ID: 10999744
    [Abstract] [Full Text] [Related]

  • 20. Increased Fas ligand expression by T cells and tumour cells in the progression of actinic keratosis to squamous cell carcinoma.
    Satchell AC, Barnetson RS, Halliday GM.
    Br J Dermatol; 2004 Jul 01; 151(1):42-9. PubMed ID: 15270871
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.